Senior Scientist, Mechanisms of Cellular Perturbation (Normal,IL) - (Normal, IL)

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. AbbVie combines the focus and passion of a leading-edge biotech with the ability and capabilities of a long-established pharmaceutical leader to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie is committed to the discovery and development of new medicines that make a remarkable impact on the lives of patients. Abbvie is making a significant push into Genomics and Genetics for drug discovery and development. In the past 2 yrs, we've made multiple investments in internal capabilities and external partnerships with leading academic groups and technology companies. In 2016 we created an internal research group, The Abbvie Genomics Research Center (GRC) within The Target Enabling Science and Technology (TEST) Department. The GRC is a single organization that drives genomics and genetics research across Abbvie R&D.